BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed AMPH catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:1df45731ab815cbfc6d1@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260616
DTEND;VALUE=DATE:20260617
SUMMARY:AMPH APPROVAL: REXTOVY
DESCRIPTION:Approved 2026-06-16: REXTOVY (NDA208969 SUPPL2)\nConfidence: co
 nfirmed\nTicker AMPH (confidence 0.6)\nSource: https://www.accessdata.fda.
 gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208969\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=208969
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:3b22d8d63586d06e0c66@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260226
DTEND;VALUE=DATE:20260227
SUMMARY:AMPH CRL: We also acknowledge receipt of your amendment dated as SP
  which was not reviewed for this action
DESCRIPTION:CRL 2026-02-26: Amphastar Pharmaceuticals\, Inc. BLA 761403 (We
  also acknowledge receipt of your amendment dated as SP which was not revi
 ewed for this action)\nConfidence: confirmed\nTicker AMPH (confidence 0.9)
 \nSource: https://download.open.fda.gov/crl/CRL_BLA761403_20260226.pdf\nSc
 heduling/reference data from public records\; dates can move. Not investme
 nt\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://download.open.fda.gov/crl/CRL_BLA761403_20260226.pdf
CATEGORIES:crl,confirmed
END:VEVENT
END:VCALENDAR
